REMI - Remedent, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue2,355.7062,770.0923,616.355
Cost of Revenue1,170.544817.3911,280.406
Gross Profit1,185.1621,952.7012,335.949
Operating Expenses
Research Development8.4248.78161.246
Selling General and Administrative2,091.7571,778.2391,914.512
Non Recurring---
Total Operating Expenses---
Operating Income or Loss-1,069.7767.218105.415
Income from Continuing Operations
Total Other Income/Expenses Net1,591.699-9.44527.025
Earnings Before Interest and Taxes859.958263.17239.103
Interest Expense36.61263.44375.06
Income Before Tax823.346199.727164.043
Income Tax Expense-3.56422.93830.565
Minority Interest69.27486.73470.747
Net Income From Continuing Ops1,182.405426.199211.822
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income1,182.405426.199211.822
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares844.37160.802105.159